17th Jun 2025 10:00
Haleon plc: Director/PDMR Shareholding
17 June 2025: Haleon plc (the "Company" or "Haleon") (LSE/NYSE:HLN) today announces notification and public disclosure in accordance with the requirements of The UK Market Abuse Regulation of a Transaction by a Person Discharging Managerial Responsibilities ("PDMR").
On 13 June 2025, the Company was notified of the following transaction as detailed below.
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name
| Marie-Anne Aymerich | |||
2
| Reason for the notification
| ||||
a)
| Position/status
| Independent Non-Executive Director - PDMR | |||
b)
| Initial notification /Amendment
| Initial Notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
| Name
| Haleon plc | |||
b)
| LEI
| 549300PSB3WWEODCUP19 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary Shares of £0.01 each
GB00BMX86B70
| |||
b)
| Nature of the transaction
| Acquisition of Ordinary Shares as a result of dividend reinvestment
| |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
£4.07 | 320 | ||||
d)
| Aggregated information | N/A | |||
- Aggregated volume | |||||
- Price | |||||
e)
| Date of the transaction
| 12 June 2025
| |||
f)
| Place of the transaction
| London Stock Exchange (XLON) | |||
Amanda Mellor
Company Secretary
About Haleon
Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.
For more information, please visit www.haleon.com.
Related Shares:
Haleon